Tenderwize
Retour à la recherche

Open-house rebate agreement for Chlortalidon

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Oct 05, 2026 · 37 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Chlortalidon, ATC C03BA04

58/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

58 / 100

Complexité

42 / 100

Facteurs de risque

For paper submissions, advance fax/scan/email/portal transmission is only timely if the original paper documents arrive...

Eligibility is limited to pharmaceutical companies and requires a signed declaration of reliability.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Nov 2026
  • Non-exclusive rebate agreements for pharmaceutical products containing Chlortalidon (ATC C03BA04).
  • Open-house model with identical, pre-set contract terms for all eligible pharmaceutical companies.
Afficher le résumé complet

Open-house supply arrangement for pharmaceutical products: AOK Bayern seeks non-exclusive rebate agreements for the active substance Chlortalidon (ATC C03BA04). The model is explicitly described as open-house, with no selection among bidders and identical non-negotiable contract terms for all eligible pharmaceutical companies. The notice provides clear submission routes and a monthly accession mechanism, but no contract value is stated.

Risques

For paper submissions, advance fax/scan/email/portal transmission is only timely if the original paper documents arrive...

Eligibility is limited to pharmaceutical companies and requires a signed declaration of reliability.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • Submission of a signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit).
  • Submission of the signed contract and the completed annex 'Festlegung der vertragsgegenständlichen Arzneimittel'.

Acheteur

Localisation

München, DEU

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open-house rebate agreement for Chlortalidon

Single lot for non-exclusive pharmaceutical rebate agreements covering Chlortalidon (ATC C03BA04). Scope is supplies of pharmaceutical products under an open-house model; contract terms are identical and not individually negotiable. Performance is in Germany, specifically Bavaria (DE212).

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Nov 2024 - Nov 2026

Catégorie

Pharmaceutical products

Date limite

Deadline Oct 05, 2026

Détails de la procédure

Date de publication
16 Oct 2024
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
628089-2024

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30